Dr. Bianca Elizabeth Russell, MD

Dr. Russell practices at UCLA Dept of Pediatric Grp Practice in Los Angeles, California.

Dr. Russell's NPI, 1548604895, was assigned on April 17, 2013. Dr. Russell graduated from UC Irvine School of Medicine in 2013. Dr. Russell's California license number on file is A154948.

Dr. Russell's primary practice is UCLA Dept of Pediatric Grp Practice, at 10833 W Le Conte Ave, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-0867.

Dr. Russell's primary practice is UCLA Dept of Pediatric Grp Practice in Los Angeles, California. The medical group on file is UCLA Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Russell practices. Vendor and product names are available with a free account.

Clinical genetics (m.d.) is Dr. Russell's primary specialty in the NPI Registry, under taxonomy code 207SG0201X. Dr. Russell is board certified in clinical genetics and genomics by the American Board of Medical Genetics and Genomics. Dmand AI has Dr. Russell's licenses on file in 2 states: California and Ohio.

Dmand AI lists intellectual and developmental disabilities among the conditions Dr. Russell treats.

CMS data shows 26 Medicare services from Dr. Russell across 2 procedure codes in 2023, all of them office visits, for 20 Medicare patients. Medicare paid $3,783 for them. Every service was in an office.

CMS counts 20 Medicare patients who saw Dr. Russell in 2024. The largest group is 85 and over, with 0 patients. 60% of them have high cholesterol. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Russell's median patient age at 10, with 46% women.

In 2024, Dr. Russell wrote 38 Medicare Part D claims. 0% of them were for generic drugs. CMS names the drug for 24 of them, across 1 drug with 11 or more claims each, at $1,236,022 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Russell for performance year 2024, reported as part of a group. Dr. Russell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Russell as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Russell in 2024. 2024 was the busiest year, with 2. Dr. Russell's most frequent co-authors are George A. Anadiotis, DO, Evdokia Anagnostou, MD and Dennis J. Chia, MD.

Dmand AI links Dr. Russell to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Bohring syndrome.

CMS Open Payments shows 24 general payments to Dr. Russell from 7 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 68% of the total. Sanofi and Genzyme US Companies paid the most, $748.

Dr. Russell graduated from UC Irvine School of Medicine in 2013.

Dr. Russell is in network with 14 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.